DAY ONE BIOPHARMACEUTICALS I's ticker is DAWN and the CUSIP is 23954D109. A total of 67 filers reported holding DAY ONE BIOPHARMACEUTICALS I in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.8%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $10,075,123 | +22.8% | 821,453 | +19.5% | 0.01% | +40.0% |
Q2 2023 | $8,205,434 | +9.0% | 687,510 | +22.2% | 0.01% | 0.0% |
Q1 2023 | $7,530,181 | -15.8% | 562,794 | -37.6% | 0.01% | +25.0% |
Q1 2022 | $8,948,000 | -46.1% | 902,020 | -11.8% | 0.00% | -42.9% |
Q4 2021 | $16,605,000 | -29.0% | 1,022,548 | +0.0% | 0.01% | -30.0% |
Q3 2021 | $23,384,000 | -16.1% | 1,022,483 | -21.2% | 0.01% | -16.7% |
Q2 2021 | $27,862,000 | – | 1,297,770 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Canaan Partners XI LLC | 2,491,561 | $30,571,453 | 26.81% |
Atlas Venture Life Science Advisors, LLC | 7,608,394 | $93,354,994 | 14.46% |
DAFNA Capital Management LLC | 586,463 | $7,195,901 | 2.24% |
Nicholas Investment Partners, LP | 2,188,654 | $26,854,785 | 2.01% |
RA Capital Management | 7,809,852 | $95,826,884 | 1.89% |
BRAIDWELL LP | 3,715,573 | $45,590,081 | 1.44% |
PFM Health Sciences, LP | 2,224,598 | $27,295,817 | 1.29% |
SPHERA FUNDS MANAGEMENT LTD. | 530,000 | $6,503,100 | 1.18% |
COMMODORE CAPITAL LP | 739,661 | $9,075,640 | 1.06% |
Parkman Healthcare Partners LLC | 466,408 | $5,722,826 | 1.05% |